An interdisciplinary research team led by the Department of Pediatrics and Adolescent Medicine and the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital has investigated the potential of liquid biops

A research team from the University of Vienna and the Medical University of Vienna is breaking new ground in precision medicine: it has developed an innovative method for analyzing metabolic profiles from finger sweat.

According to the WHO, 30 to 50 per cent of all cancers could be prevented by lifestyle measures, vaccinations or environmental factors.

In a paper recently published in the leading journal "The Lancet Digital Health", a scientific team led by Stanisa Raspopovic from MedUni Vienna looks at the progress and challenges in the research and development of brain implants.

Researchers at MedUni Vienna have joined forces with the Viennese start-up TAmiRNA to develop a test that aims to improve the safety of liver surgery. The invention by Alice Assinger and Patrick Starlinger is based on the precise analysis of circulating microRNAs and is now ready for the market.

The new Ignaz Semmelweis Institute started its work at the beginning of 2025. This facility in the field of infection research is a merger of the Medical Universities of Vienna, Innsbruck and Graz, the Johannes Kepler University Linz and the University of Veterinary Medicine Vienna.

A study by the Medical University of Vienna investigated the development of utilisation of various levels of the Austrian healthcare system between 2006 and 2019.

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in persons with haemophilia A, the most common form of haemophilia. The research team was able to show that saliva contains special vesicles that trigger rapid coagulation of the blood of haemophilic patients. The results, which were recently published in the renowned scientific journal "Blood", contribute significantly to a better understanding of the disease.

In an important step towards improving epilepsy treatment in Georgia, a team of experts from MedUni Vienna successfully collaborated with Georgian colleagues as part of the ILAE Mentorship Programme.

The Transplantation Research Platform of the Medical University of Vienna is awarding two "Start up Grants" to support young scientists in the field of transplant research. Anna Weijler and Konstantin Doberer receive funding for their projects on cell therapy and the microbiome.

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumours in particular can be difficult to treat surgically.

A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

Researchers at CeMM and the Medical University of Vienna have developed an innovative microscopy-based approach that could predict the best approved drug to treat individual rheumatoid arthritis patients using samples of their blood. Published in the Lancet group journal EBioMedicine the study demonstrates the feasibility of precision medicine to significantly enhance treatments for rheumatoid arthritis and likely other autoimmune diseases.

An innovative study by the Karl Landsteiner University of Health Sciences (KL Krems) and the Medical University of Vienna (MedUni Vienna) provides new insights into the genetic mechanisms of birch pollen allergy.

A research team from the Medical University of Vienna, the University of Vienna and the Yale School of Public Health has analysed the way breastfeeding and commercial milk formula are presented in

Allergy sufferers in Vienna and eastern Austria need to be prepared for the start of the hazel pollen season.